Literature DB >> 11781270

Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Michelle C Callegan1, Michael Engelbert, David W Parke, Bradley D Jett, Michael S Gilmore.   

Abstract

Endophthalmitis is a severe inflammation of the interior of the eye caused by the introduction of contaminating microorganisms following trauma, surgery, or hematogenous spread from a distant infection site. Despite appropriate therapeutic intervention, bacterial endophthalmitis frequently results in visual loss, if not loss of the eye itself. Although the pathogenicity of bacterial endophthalmitis has historically been linked with toxin production during infection, a paucity of information exists as to the exact mechanisms of retinal toxicity and the triggers for induction of the intraocular immune response. Recently, research has begun to examine the bacterial and host molecular and cellular events that contribute to ocular damage during endophthalmitis. This review focuses on the causative agents and therapeutic challenges of bacterial endophthalmitis and provides current data from the analysis of the role of bacterial virulence factors and host inflammatory interactions in the pathogenesis of eye infections. Based on these and related studies, a hypothetical model for the molecular pathogenesis of bacterial endophthalmitis is proposed. Identifying and understanding the basic mechanisms of these bacterium-host interactions will provide the foundation for which novel, information-based therapeutic agents are developed in order to prevent vision loss during endophthalmitis.

Entities:  

Mesh:

Year:  2002        PMID: 11781270      PMCID: PMC118063          DOI: 10.1128/CMR.15.1.111-124.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  148 in total

1.  Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study.

Authors:  D P Han; S R Wisniewski; L A Wilson; M Barza; A K Vine; B H Doft; S F Kelsey
Journal:  Am J Ophthalmol       Date:  1996-07       Impact factor: 5.258

2.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 3.  The use of corticosteroids in the management of bacterial meningitis in adults.

Authors:  G C Townsend; W M Scheld
Journal:  J Antimicrob Chemother       Date:  1996-06       Impact factor: 5.790

4.  Endogenous endophthalmitis due to Escherichia coli: case report and review.

Authors:  C Y Tseng; P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

5.  Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.

Authors:  I T Kim; K H Chung; B S Koo
Journal:  Korean J Ophthalmol       Date:  1996-06

6.  Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production.

Authors:  Y S Kim; M G Täuber
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Comparative treatment of experimental Staphylococcus aureus endophthalmitis.

Authors:  H E Aguilar; T A Meredith; C Drews; H Grossniklaus; A D Sawant; S Gardner
Journal:  Am J Ophthalmol       Date:  1996-03       Impact factor: 5.258

8.  Useful visual outcomes after treatment of Bacillus cereus endophthalmitis.

Authors:  R E Foster; J A Martinez; T G Murray; P E Rubsamen; H W Flynn; R K Forster
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

9.  Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation.

Authors:  K Sato; M K Quartey; C L Liebeler; G S Giebink
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  104 in total

Review 1.  The microbiology of endophthalmitis: global trends and a local perspective.

Authors:  Y Keynan; Y Finkelman; P Lagacé-Wiens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-05       Impact factor: 3.267

Review 2.  The role of ATP-binding cassette transporters in bacterial pathogenicity.

Authors:  Victoria G Lewis; Miranda P Ween; Christopher A McDevitt
Journal:  Protoplasma       Date:  2012-01-13       Impact factor: 3.356

3.  Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study.

Authors:  Muammer Ozcimen; Yasar Sakarya; Serap Ozcimen; Sertan Goktas; Rabia Sakarya; Ismail Alpfidan; Erkan Erdogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-23       Impact factor: 3.117

4.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

5.  Actinomyces endophthalmitis and pneumonia in a dog.

Authors:  Laura D Barnes; Bruce H Grahn
Journal:  Can Vet J       Date:  2007-11       Impact factor: 1.008

Review 6.  [Endogenous endophthalmitis].

Authors:  T Ness
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

Review 7.  Skin microbiota: a source of disease or defence?

Authors:  A L Cogen; V Nizet; R L Gallo
Journal:  Br J Dermatol       Date:  2008-03       Impact factor: 9.302

8.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

Review 9.  MR imaging findings of endophthalmitis.

Authors:  Rupa Radhakrishnan; Rebecca Cornelius; Mary Beth Cunnane; Karl Golnik; Humberto Morales
Journal:  Neuroradiol J       Date:  2016-02-25

10.  Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis.

Authors:  Michelle C Callegan; Daniel C Cochran; Scott T Kane; Michael S Gilmore; Myriam Gominet; Didier Lereclus
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.